THE PHARMACOLOGY OF PRODRUGS OF 5-FLUOROURACIL AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE

被引：33
作者：
HADFIELD, AF
SARTORELLI, AC
机构：
[1] YALE UNIV,SCH MED,CTR COMPREHENS CANC,DEPT PHARMACOL,NEW HAVEN,CT 06510
[2] YALE UNIV,SCH MED,CTR COMPREHENS CANC,DEV THERAPEUT PROGRAM,NEW HAVEN,CT 06510
来源：
ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY | 1984年 / 20卷
关键词：
D O I：
10.1016/S1054-3589(08)60264-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：21 / 67
页数：47
相关论文
共 275 条
[1]  
ABELE R, 1982, CANCER TREAT REP, V66, P1307
[2]   CHEMICAL ASPECTS OF SELECTIVE TOXICITY [J].
ALBERT, A .
NATURE, 1958, 182 (4633) :421-423
[3]  
ALBERTO P, 1977, P AM ASSOC CANC RES, V18, P231
[4]  
ALBERTO P, 1976, CANCER TREAT REP, V60, P281
[5]   PHASE-2 STUDY OF ANHYDRO-ARA-5-FLUOROCYTIDINE IN ADENOCARCINOMA OF GASTROINTESTINAL-TRACT, EPIDERMOID CARCINOMA OF LUNG, HEAD AND NECK, BREAST CARCINOMA AND SMALL CELL ANAPLASTIC CARCINOMA OF LUNG - STUDY REPORT OF EORTC EARLY CLINICAL TRIAL COOPERATIVE GROUP [J].
ALBERTO, P ;
ROZENCWEIG, M ;
GANGJI, D ;
BRUGAROLAS, A ;
CAVALLI, F ;
SIEGENTHALER, P ;
HANSEN, HH ;
SYLVESTER, R .
EUROPEAN JOURNAL OF CANCER, 1978, 14 (02) :195-201
[6]  
Amidon G. L., 1977, DESIGN BIOPHARMACEUT, P281
[7]  
AOSHIMA M, 1976, CANCER RES, V36, P2726
[8]  
AOSHIMA M, 1977, CANCER RES, V37, P2481
[9]  
ARMSTRONG RD, 1980, CANCER RES, V40, P3333
[10]  
AU JL, 1979, CANCER RES, V39, P4289
12345678910